Form D/A - Notice of Exempt Offering of Securities: [Amend]
SEC Accession No. 0001676987-17-000001
Filing Date
2017-12-12
Accepted
2017-12-12 10:48:50
Documents
1
Effectiveness Date
2017-12-12
Items
Item 06b:

Document Format Files

Seq Description Document Type Size
1 primary_doc.html D/A  
1 primary_doc.xml D/A 6539
  Complete submission text file 0001676987-17-000001.txt   7612
Mailing Address 20600 CHAGRIN BLVD. SUITE 210 CLEVELAND OH 44122
Business Address 20600 CHAGRIN BLVD. SUITE 210 CLEVELAND OH 44122 216-455-3216
Allinaire Therapeutics, LLC (Filer) CIK: 0001676987 (see all company filings)

EIN.: 810774310 | State of Incorp.: DE | Fiscal Year End: 1231
Type: D/A | Act: 33 | File No.: 021-276461 | Film No.: 171251118